Additionally, the lncRNA PCAT1 rs2632159 may impact the risk of CRC by modulating the binding of EBF, LUN-1, and TCF12 [78], which could stimulate PCAT1 expression, thus increasing its oncogenic function. This evidence concerns the gene EBF1 and colorectal carcinoma.